- Home
- GATX vs PCVX Comparison
GATX vs PCVX Comparison
Compare GATX & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GATX
- PCVX
- Stock Information
- Founded
- GATX 1898
- PCVX 2013
- Country
- GATX United States
- PCVX United States
- Employees
- GATX N/A
- PCVX N/A
- Industry
- GATX Transportation Services
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- GATX Consumer Discretionary
- PCVX Health Care
- Exchange
- GATX Nasdaq
- PCVX Nasdaq
- Market Cap
- GATX 5.9B
- PCVX 4.4B
- IPO Year
- GATX N/A
- PCVX 2020
- Fundamental
- Price
- GATX $167.66
- PCVX $30.79
- Analyst Decision
- GATX Buy
- PCVX Strong Buy
- Analyst Count
- GATX 2
- PCVX 10
- Target Price
- GATX $172.50
- PCVX $136.50
- AVG Volume (30 Days)
- GATX 156.8K
- PCVX 1.5M
- Earning Date
- GATX 10-21-2025
- PCVX 08-06-2025
- Dividend Yield
- GATX 1.45%
- PCVX N/A
- EPS Growth
- GATX 34.45
- PCVX N/A
- EPS
- GATX 8.74
- PCVX N/A
- Revenue
- GATX $1,671,000,000.00
- PCVX N/A
- Revenue This Year
- GATX $10.94
- PCVX N/A
- Revenue Next Year
- GATX $4.66
- PCVX N/A
- P/E Ratio
- GATX $19.26
- PCVX N/A
- Revenue Growth
- GATX 11.74
- PCVX N/A
- 52 Week Low
- GATX $127.70
- PCVX $27.66
- 52 Week High
- GATX $171.62
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- GATX 73.71
- PCVX 42.01
- Support Level
- GATX $163.48
- PCVX $29.87
- Resistance Level
- GATX $166.62
- PCVX $31.44
- Average True Range (ATR)
- GATX 2.93
- PCVX 1.18
- MACD
- GATX 1.28
- PCVX 0.01
- Stochastic Oscillator
- GATX 92.69
- PCVX 28.32
About GATX GATX Corporation
GATX Corp is a provider of railcar leasing and maintenance services. GATX operates in business segments including rail North America, rail international, Engine Leasing, and others. The rail business offers railcar leasing and maintenance, as well as asset-related, financial, and management services. The company owns and leases fleets in North America, Europe, and Asia, which consist of tank and freight railcars. Industries served include refining and petroleum, chemicals and plastics, railroads and other transportation, mining, and food and agriculture.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.